These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 23686699)
1. UGT1A1 6/28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients. Gao J; Zhou J; Li Y; Lu M; Jia R; Shen L Med Oncol; 2013; 30(3):604. PubMed ID: 23686699 [TBL] [Abstract][Full Text] [Related]
2. Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients. Gao J; Zhou J; Li Y; Peng Z; Li Y; Wang X; Shen L Med Oncol; 2013; 30(3):630. PubMed ID: 23783485 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between UGT1A1 gene polymorphisms and irinotecan-induced severe adverse events]. Wang XF; Ma C; Gong FF; Yi SY; Xing GC; Wang KJ; Yang Q; Cao W Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):594-599. PubMed ID: 30139029 [No Abstract] [Full Text] [Related]
4. UGT1A1 Gene Polymorphism Predicts Irinotecan-Induced Severe Neutropenia and Diarrhea in Chinese Cancer Patients. Peng H; Duan Z; Pan D; Wen J; Wei X Clin Lab; 2017 Sep; 63(9):1339-1346. PubMed ID: 28879724 [TBL] [Abstract][Full Text] [Related]
5. Correlation of UGT1A1(*)28 and (*)6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients. Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Chamnanphon M; Puangpetch A; Wongwaisayawan S; Sukasem C Drug Metab Pharmacokinet; 2016 Feb; 31(1):90-94. PubMed ID: 26830078 [TBL] [Abstract][Full Text] [Related]
6. Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens. Yang C; Liu Y; Xi WQ; Zhou CF; Jiang JL; Ma T; Ye ZB; Zhang J; Zhu ZG Drug Des Devel Ther; 2015; 9():3677-83. PubMed ID: 26229432 [TBL] [Abstract][Full Text] [Related]
7. Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis. Liu D; Li J; Gao J; Li Y; Yang R; Shen L BMC Cancer; 2017 Jun; 17(1):437. PubMed ID: 28637434 [TBL] [Abstract][Full Text] [Related]
8. UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma. Liu CY; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Wang WS Cancer; 2008 May; 112(9):1932-40. PubMed ID: 18300238 [TBL] [Abstract][Full Text] [Related]
9. UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis. Zhang X; Yin JF; Zhang J; Kong SJ; Zhang HY; Chen XM Cancer Chemother Pharmacol; 2017 Jul; 80(1):135-149. PubMed ID: 28585035 [TBL] [Abstract][Full Text] [Related]
10. UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil. Wang Y; Shen L; Xu N; Wang JW; Jiao SC; Liu ZY; Xu JM World J Gastroenterol; 2012 Dec; 18(45):6635-44. PubMed ID: 23236239 [TBL] [Abstract][Full Text] [Related]
11. [Correlation between nUGT1A1 gene polymorphisms and adverse events of irinotecan plus S-1 for patients with recurrent or metastatic esophageal squamous cell carcinoma: a prospective, open-label, randomized controlled trial (ESWN 01)]. Wang X; Liu Y; Huang JX; Lu P; Ba Y; Wu L; Bai YX; Zhang S; Feng JF; Cheng Y; Li J; Wen L; Yuan XL; Ma CW; Hu CH; Fan QX; Xu BH; Huang J Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1177-1182. PubMed ID: 34794220 [No Abstract] [Full Text] [Related]
12. UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan. Hazama S; Mishima H; Tsunedomi R; Okuyama Y; Kato T; Takahashi K; Nozawa H; Ando H; Kobayashi M; Takemoto H; Nagata N; Kanekiyo S; Inoue Y; Hamamoto Y; Fujita Y; Hinoda Y; Okayama N; Oba K; Sakamoto J; Oka M Cancer Sci; 2013 Dec; 104(12):1662-9. PubMed ID: 24033692 [TBL] [Abstract][Full Text] [Related]
13. [Polymorphisms of UGT1A gene and irinotecan toxicity in Chinese colorectal cancer patients]. Wang Y; Xu JM; Shen L; Xu N; Wang JW; Jiao SC; Zhang JS; Song ST; Li J; Bao HY; Yang L; Li F Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):913-6. PubMed ID: 18478930 [TBL] [Abstract][Full Text] [Related]
14. Effects of UGT1A1*6, UGT1A1*28, and ABCB1-3435C>T polymorphisms on irinotecan induced toxicity in Chinese cancer patients. Yan L; Wang XF; Wei LM; Nie YL; Liu JY; Zhang LR Int J Clin Pharmacol Ther; 2016 Mar; 54(3):193-9. PubMed ID: 26857783 [TBL] [Abstract][Full Text] [Related]
15. Increased frequency of uridine diphosphate glucuronosyltransferase 1A1 7/7 in patients experiencing severe irinotecan-induced toxicities. Fakih MG; Ross ME; Starostik P Clin Colorectal Cancer; 2007 Jul; 6(8):583-7. PubMed ID: 17681105 [TBL] [Abstract][Full Text] [Related]
16. Correlation between UGT1A1 gene polymorphism and irinotecan chemotherapy in metastatic colorectal cancer: a study from Guangxi Zhuang. Chen S; Hua L; Feng C; Mo Q; Wei M; Shen Y; Lin Z; Li G; Xu J; Guo C; Huang H BMC Gastroenterol; 2020 Apr; 20(1):96. PubMed ID: 32264830 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients. Hirasawa A; Zama T; Akahane T; Nomura H; Kataoka F; Saito K; Okubo K; Tominaga E; Makita K; Susumu N; Kosaki K; Tanigawara Y; Aoki D J Hum Genet; 2013 Dec; 58(12):794-8. PubMed ID: 24088669 [TBL] [Abstract][Full Text] [Related]
18. UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis. Chen X; Liu L; Guo Z; Liang W; He J; Huang L; Deng Q; Tang H; Pan H; Guo M; Liu Y; He Q; He J Cancer Chemother Pharmacol; 2017 Jun; 79(6):1109-1117. PubMed ID: 28502040 [TBL] [Abstract][Full Text] [Related]
19. Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients. Han FF; Guo CL; Yu D; Zhu J; Gong LL; Li GR; Lv YL; Liu H; An GY; Liu LH Cancer Chemother Pharmacol; 2014 Apr; 73(4):779-88. PubMed ID: 24519753 [TBL] [Abstract][Full Text] [Related]
20. UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer. Xu C; Tang X; Qu Y; Keyoumu S; Zhou N; Tang Y Cancer Chemother Pharmacol; 2016 Jul; 78(1):119-30. PubMed ID: 27220761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]